| 2007 | The intention to treat analysis of the different post-remission therapy modalities in AML patients with the Intermediate Risk Group based on cytogenetics | 문영철 | Meeting Abstract |
| 2007 | CD34, RAB20, DLK1, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2007 | Early imatinib mesylate-induced hepatotoxicity in chronic myelogenous leukaemia | 이순남; 성주명; 조민선; 이경은; 문영철; 남은미 | Article |
| 2007 | Gene expression profile related to prognosis of acute myeloid leukemia | 성주명; 이경은; 문영철 | Article |
| 2007 | Outgrowing endothelial cells that are derived from human umbilical cord blood improve neovascularization in hind-limb ischemia. | 성주명; 유은선; 권기환; 이경은; 문영철 | Meeting Abstract |
| 2007 | Hematopoietic stem cells mobilization by G-CSF and LTB4 was significantly suppressed by an oxygen radical scavenger or an inhibitor of NADPH oxidase | 성주명; 유은선; 이경은; 문영철 | Meeting Abstract |
| 2007 | The equal activity of azacytidine in 4 risk groups of IPSS in MDS | 문영철 | Meeting Abstract |
| 2007 | The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea. | 문영철 | Meeting Abstract |
| 2007 | Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Article |
| 2007 | Restoration of peroxiredoxins and catalase is closely correlated with the level of Philadelphia chromosome during imatinib therapy in CML | 성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 우현애 | Meeting Abstract |
